Related Experiment Video
Updated: Jun 8, 2026
13:08
Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Published on: September 9, 2011
Anticancer properties of zoledronic acid
1Novartis Pharma AG, Switzerland.
Cancer Investigation
|October 1, 2010
Summary
Zoledronic acid, used for bone cancer, shows potential anticancer effects by inhibiting tumor growth and spread. Further research is ongoing to understand its role in cancer treatment.
Area of Science:
- Oncology
- Pharmacology
Background:
- Zoledronic acid is established in managing skeletal-related events in metastatic bone cancer.
- Emerging evidence suggests potential direct anticancer activities of zoledronic acid.
Purpose of the Study:
- To explore the anticancer properties of zoledronic acid beyond its skeletal benefits.
- To investigate the mechanisms by which zoledronic acid may inhibit cancer progression.
Main Methods:
- Review of preclinical data from animal models involving zoledronic acid and anticancer therapies.
- Analysis of in vitro studies examining zoledronic acid's effects on tumor cells.
- Evaluation of early clinical data on zoledronic acid in cancer patients.
Main Results:
- Preclinical studies demonstrate zoledronic acid's ability to inhibit soft-tissue tumor growth, proliferation, and angiogenesis.
- Zoledronic acid treatment in models also showed increased apoptosis, altered macrophage function, and enhanced immune surveillance.
- In vitro and pilot clinical data suggest zoledronic acid may inhibit tumor cell dissemination and improve patient outcomes.
Conclusions:
- Zoledronic acid exhibits promising anticancer properties, including inhibition of tumor growth, metastasis, and enhancement of anti-tumor immunity.
- The drug may play a significant role in improving outcomes for cancer patients, warranting further investigation.
- Ongoing clinical trials are crucial to fully establish the therapeutic potential of zoledronic acid in oncology.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...